299 related articles for article (PubMed ID: 16007614)
1. Nondopaminergic mechanisms in levodopa-induced dyskinesia.
Brotchie JM
Mov Disord; 2005 Aug; 20(8):919-31. PubMed ID: 16007614
[TBL] [Abstract][Full Text] [Related]
2. The pharmacology of L-DOPA-induced dyskinesia in Parkinson's disease.
Huot P; Johnston TH; Koprich JB; Fox SH; Brotchie JM
Pharmacol Rev; 2013 Jan; 65(1):171-222. PubMed ID: 23319549
[TBL] [Abstract][Full Text] [Related]
3. The neural mechanisms underlying levodopa-induced dyskinesia in Parkinson's disease.
Brotchie JM
Ann Neurol; 2000 Apr; 47(4 Suppl 1):S105-12; discussion S112-4. PubMed ID: 10762137
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease.
Mela F; Marti M; Dekundy A; Danysz W; Morari M; Cenci MA
J Neurochem; 2007 Apr; 101(2):483-97. PubMed ID: 17359492
[TBL] [Abstract][Full Text] [Related]
5. A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment.
Crossman AR
Mov Disord; 1990; 5(2):100-8. PubMed ID: 1970120
[TBL] [Abstract][Full Text] [Related]
6. L-dopa-induced dyskinesia and stereotactic surgery for Parkinson's disease.
Guridi J; Obeso JA; Rodriguez-Oroz MC; Lozano AA; Manrique M
Neurosurgery; 2008 Feb; 62(2):311-23; discussion 323-5. PubMed ID: 18382309
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology of levodopa-induced dyskinesia: potential for new therapies.
Bezard E; Brotchie JM; Gross CE
Nat Rev Neurosci; 2001 Aug; 2(8):577-88. PubMed ID: 11484001
[TBL] [Abstract][Full Text] [Related]
8. L-DOPA-induced dyskinesia: cellular mechanisms and approaches to treatment.
Cenci MA
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S263-7. PubMed ID: 18267248
[TBL] [Abstract][Full Text] [Related]
9. Parkinson's disease--opportunities for novel therapeutics to reduce the problems of levodopa therapy.
Fox SH; Chuang R; Brotchie JM
Prog Brain Res; 2008; 172():479-94. PubMed ID: 18772047
[TBL] [Abstract][Full Text] [Related]
10. Advances in understanding L-DOPA-induced dyskinesia.
Cenci MA; Lindgren HS
Curr Opin Neurobiol; 2007 Dec; 17(6):665-71. PubMed ID: 18308560
[TBL] [Abstract][Full Text] [Related]
11. Levodopa-induced dyskinesia in Parkinson's disease.
Brotchie JM; Lee J; Venderova K
J Neural Transm (Vienna); 2005 Mar; 112(3):359-91. PubMed ID: 15614429
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of L-DOPA-induced dyskinesia.
Jenner P
Nat Rev Neurosci; 2008 Sep; 9(9):665-77. PubMed ID: 18714325
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacological mechanisms of the treatment of dyskinesias in Parkinson disease].
Jiménez-Jiménez FJ; Molina JA; Ortí-Pareja M
Rev Neurol; 1999 May 1-15; 28(9):889-98. PubMed ID: 10390756
[TBL] [Abstract][Full Text] [Related]
14. New approaches to therapy.
Brotchie J; Jenner P
Int Rev Neurobiol; 2011; 98():123-50. PubMed ID: 21907085
[TBL] [Abstract][Full Text] [Related]
15. Serotonergic involvement in levodopa-induced dyskinesias in Parkinson's disease.
Cheshire PA; Williams DR
J Clin Neurosci; 2012 Mar; 19(3):343-8. PubMed ID: 22249009
[TBL] [Abstract][Full Text] [Related]
16. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.
Morgante F; Espay AJ; Gunraj C; Lang AE; Chen R
Brain; 2006 Apr; 129(Pt 4):1059-69. PubMed ID: 16476674
[TBL] [Abstract][Full Text] [Related]
17. Enhanced preproenkephalin-B-derived opioid transmission in striatum and subthalamic nucleus converges upon globus pallidus internalis in L-3,4-dihydroxyphenylalanine-induced dyskinesia.
Aubert I; Guigoni C; Li Q; Dovero S; Bioulac BH; Gross CE; Crossman AR; Bloch B; Bezard E
Biol Psychiatry; 2007 Apr; 61(7):836-44. PubMed ID: 16950226
[TBL] [Abstract][Full Text] [Related]
18. Morphological and electrophysiological changes in intratelencephalic-type pyramidal neurons in the motor cortex of a rat model of levodopa-induced dyskinesia.
Ueno T; Yamada J; Nishijima H; Arai A; Migita K; Baba M; Ueno S; Tomiyama M
Neurobiol Dis; 2014 Apr; 64():142-9. PubMed ID: 24398173
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of l-DOPA-induced dyskinesia.
Fisone G; Bezard E
Int Rev Neurobiol; 2011; 98():95-122. PubMed ID: 21907084
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors.
Guigoni C; Aubert I; Li Q; Gurevich VV; Benovic JL; Ferry S; Mach U; Stark H; Leriche L; Håkansson K; Bioulac BH; Gross CE; Sokoloff P; Fisone G; Gurevich EV; Bloch B; Bezard E
Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S25-9. PubMed ID: 15885624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
